Serotonin reuptake inhibitor (SRI) medications are well established as first-line
pharmacotherapeutic treatment for Obsessive-Compulsive Disorder (OCD). However …

Depression is a common mental health issue that affects 280 million people in the world with
a high mortality rate, as well as being a leading cause of disability. Psychopharmacological …

Obsessive compulsive disorder (OCD) is a highly prevalent disorder that causes serious
disability. Available treatments leave 40% or more of people with OCD significantly …

Psychedelic mushrooms containing psilocybin and related tryptamines have long been used
for ethnomycological purposes, but emerging evidence points to the potential therapeutic …

A renewed interest in the use of psychedelics for treating obsessive compulsive disorder
(OCD) has emerged in the last 20 years. But pre-clinical and clinical evidence remain …

Background: Clinical use of psychedelics has gained considerable attention, with promising
benefits across a range of mental disorders. Current pharmacological and …

Preliminary clinical findings, supported by preclinical studies employing behavioral
paradigms such as marble burying, suggest that psilocybin may be effective in treating …

Classic psychedelics, such as psilocybin, act on the brain's serotonin system and produce
striking psychological effects. Early work in the 1950s and 1960s and more recent controlled …

Objective Emerging research suggests that the use of serotonergic psychedelics can be
associated with reductions in obsessions and compulsions. However, little research to date …

Psilocybin (a classic serotonergic psychedelic drug) has received appraisal for use in
psychedelic-assisted therapy of several psychiatric disorders. A less explored topic …